These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 11372006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relationship between acetylation polymorphism and risk of atopic diseases.
    Gawrońska-Szklarz B, Luszawska-Kutrzeba T, Czaja-Bulsa G, Kurzawski G.
    Clin Pharmacol Ther; 1999 May; 65(5):562-9. PubMed ID: 10340922
    [Abstract] [Full Text] [Related]

  • 4. Association between the N-acetylation genetic polymorphism and bronchial asthma.
    Nacak M, Aynacioglu AS, Filiz A, Cascorbi I, Erdal ME, Yilmaz N, Ekinci E, Roots I.
    Br J Clin Pharmacol; 2002 Dec; 54(6):671-4. PubMed ID: 12492617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases.
    Zielińska E, Niewiarowski W, Bodalski J, Stańczyk A, Bolanowski W, Rebowski G.
    Clin Pharmacol Ther; 1997 Dec; 62(6):635-42. PubMed ID: 9433392
    [Abstract] [Full Text] [Related]

  • 10. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
    Skretkowicz K, Skretkowicz J, Gawrońska-Szklarz B, Górnik W, Rychlik-Sych M, Sysa-Jedrzejowska A.
    Eur J Clin Pharmacol; 2005 Jan; 60(11):773-8. PubMed ID: 15565348
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV, Mohammadi F, Bahadori M, Sheikholslami M, Javeri A, Masjedi MR, Velayati AA.
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population.
    Bialecka M, Gawronska-Szklarz B, Drozdzik M, Honczarenko K, Stankiewicz J.
    Eur J Clin Pharmacol; 2002 Feb; 57(12):857-62. PubMed ID: 11936704
    [Abstract] [Full Text] [Related]

  • 17. Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus.
    Mrozikiewicz PM, Drakoulis N, Roots I.
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):626-34. PubMed ID: 7995004
    [Abstract] [Full Text] [Related]

  • 18. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
    Huang YS, Chern HD, Su WJ, Wu JC, Lai SL, Yang SY, Chang FY, Lee SD.
    Hepatology; 2002 Apr; 35(4):883-9. PubMed ID: 11915035
    [Abstract] [Full Text] [Related]

  • 19. [NAT2* genotype in children with bronchial asthma and other atopic diseases].
    Luszawska-Kutrzeba T.
    Ann Acad Med Stetin; 1999 Apr; 45():109-21. PubMed ID: 10909485
    [Abstract] [Full Text] [Related]

  • 20. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C, Washio M, Horiuchi T, Tada Y, Asami T, Ide S, Takahashi H, Kobashi G, Kyushu Sapporo SLE (KYSS) Study Group.
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.